Peptide intra-tumor injection for cancer immunotherapy: Enhancement of tumor cell antigenicity is a novel and attractive strategy

One of the problems in antigen-specific cancer immunotherapy is the low density of the tumor antigen-derived peptide endogenously presented on tumor cell surface major histocompatibility complex class I molecules. To overcome this, we are engaged in research on peptide intra-tumor injection to enhan...

Descripción completa

Detalles Bibliográficos
Autores principales: Nobuoka, Daisuke, Yoshikawa, Toshiaki, Fujiwara, Toshiyoshi, Nakatsura, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901811/
https://www.ncbi.nlm.nih.gov/pubmed/23411443
http://dx.doi.org/10.4161/hv.23990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901811/
https://www.ncbi.nlm.nih.gov/pubmed/23411443
http://dx.doi.org/10.4161/hv.23990

Ejemplares similares